Open Residency cover image

Joel Kocher - This $200M CEO Discovered What Cardiologists Won't Tell You

Open Residency

00:00

From Research to Product: Humann's Development

Joel outlines Humann's R&D journey, prototype testing, and creation of a saliva diagnostic to measure nitric oxide effect.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app